219 related articles for article (PubMed ID: 30950095)
1. The emergence of melatonin in oncology: Focus on colorectal cancer.
Gil-Martín E; Egea J; Reiter RJ; Romero A
Med Res Rev; 2019 Nov; 39(6):2239-2285. PubMed ID: 30950095
[TBL] [Abstract][Full Text] [Related]
2. The potential therapeutic actions of melatonin in colorectal cancer.
Chok KC; Ng CH; Koh RY; Ng KY; Chye SM
Horm Mol Biol Clin Investig; 2019 May; 39(1):. PubMed ID: 31141480
[TBL] [Abstract][Full Text] [Related]
3. Melatonin for the prevention and treatment of cancer.
Li Y; Li S; Zhou Y; Meng X; Zhang JJ; Xu DP; Li HB
Oncotarget; 2017 Jun; 8(24):39896-39921. PubMed ID: 28415828
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Opportunities in Colorectal Cancer: Focus on Melatonin Antioncogenic Action.
Wu H; Liu J; Yin Y; Zhang D; Xia P; Zhu G
Biomed Res Int; 2019; 2019():9740568. PubMed ID: 31637261
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota.
Pan S; Guo Y; Hong F; Xu P; Zhai Y
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166281. PubMed ID: 34610472
[TBL] [Abstract][Full Text] [Related]
6. The Role of Melatonin in Colorectal Cancer.
Iravani S; Eslami P; Dooghaie Moghadam A; Moazzami B; Mehrvar A; Hashemi MR; Mansour-Ghanaei F; Mansour-Ghanaei A; Majidzadeh-A K
J Gastrointest Cancer; 2020 Sep; 51(3):748-753. PubMed ID: 31792737
[TBL] [Abstract][Full Text] [Related]
7. Melatonin as a potential inhibitor of colorectal cancer: Molecular mechanisms.
Shafabakhsh R; Reiter RJ; Davoodabadi A; Asemi Z
J Cell Biochem; 2019 Aug; 120(8):12216-12223. PubMed ID: 31087705
[TBL] [Abstract][Full Text] [Related]
8. Understanding the oncostatic actions displayed by melatonin in colorectal cancer therapy.
Gil-Martín E; López-Muñoz F; Reiter RJ; Romero A
Future Med Chem; 2020 Jul; 12(13):1201-1204. PubMed ID: 32466682
[No Abstract] [Full Text] [Related]
9. AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors.
Casado J; Iñigo-Chaves A; Jiménez-Ruiz SM; Ríos-Arrabal S; Carazo-Gallego Á; González-Puga C; Núñez MI; Ruíz-Extremera Á; Salmerón J; León J
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604612
[TBL] [Abstract][Full Text] [Related]
10. A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates.
Barni S; Lissoni P; Cazzaniga M; Ardizzoia A; Meregalli S; Fossati V; Fumagalli L; Brivio F; Tancini G
Oncology; 1995; 52(3):243-5. PubMed ID: 7715908
[TBL] [Abstract][Full Text] [Related]
11. Melatonin: An important anticancer agent in colorectal cancer.
Mirza-Aghazadeh-Attari M; Mohammadzadeh A; Mostavafi S; Mihanfar A; Ghazizadeh S; Sadighparvar S; Gholamzadeh S; Majidinia M; Yousefi B
J Cell Physiol; 2020 Feb; 235(2):804-817. PubMed ID: 31276205
[TBL] [Abstract][Full Text] [Related]
12. [Melatonin in complex treatment for colorectal cancer patients].
Pliss MM
Vopr Onkol; 2016; 62(3):413-7. PubMed ID: 30462903
[TBL] [Abstract][Full Text] [Related]
13. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
[TBL] [Abstract][Full Text] [Related]
14. The validity of melatonin as an oncostatic agent.
Panzer A; Viljoen M
J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
[TBL] [Abstract][Full Text] [Related]
15. Potential role of melatonin in prevention and treatment of leukaemia.
Ng MG; Ng KY; Koh RY; Chye SM
Horm Mol Biol Clin Investig; 2021 Aug; 42(4):445-461. PubMed ID: 34355548
[TBL] [Abstract][Full Text] [Related]
16. Melatonin and cancer suppression: insights into its effects on DNA methylation.
Davoodvandi A; Nikfar B; Reiter RJ; Asemi Z
Cell Mol Biol Lett; 2022 Sep; 27(1):73. PubMed ID: 36064311
[TBL] [Abstract][Full Text] [Related]
17. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
Kasprzak A; Adamek A
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA: A new player in response to therapy for colorectal cancer.
Sarvizadeh M; Malekshahi ZV; Razi E; Sharifi H; Moussavi N; Taghizadeh M
J Cell Physiol; 2019 Jun; 234(6):8533-8540. PubMed ID: 30478837
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic actions of melatonin in cancer: possible mechanisms.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells in colorectal cancer: a review.
Munro MJ; Wickremesekera SK; Peng L; Tan ST; Itinteang T
J Clin Pathol; 2018 Feb; 71(2):110-116. PubMed ID: 28942428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
